Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC12644	GW406108X	GW406108X (GW-406108X, GW108X) is specific inhibitor of Kif15 (Kinesin-12) with IC50 of 0.82 uM in ATPase assays.
DC7662	GW4869 Featured	GW4869 is a cell permeable, selective inhibitor of N-SMase (neutral sphingomyelinase).
DC23530	GW-766994 R-form	GW-766994 (GW766994) is a potent, selective, orally available CCR3 antagonist with pKi of 7.86 for inhibiting eotaxin-induced eosinophil chemotaxis in vitro assays.
DC23531	GW-766994	GW-766994 (GW766994) is a potent, selective, orally available CCR3 antagonist with pKi of 7.86 for inhibiting eotaxin-induced eosinophil chemotaxis in vitro assays.
DC22653	GW-8510 Featured	GW-8510 (GW8510) is a potent, selective inhibitor of CDK2 with IC50 of 10 nM.
DC1086	GW-9508 Featured	GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.
DC26080	GX-674 Featured	GX-674 is a potent, selective Nav1.7 inhibitor with IC50 of 0.1 nM.
DC23613	GX-936	GX-936 (PF 05196233) is a potent Nav1.7 inhibitor that binds to the activated state of voltage-sensor domain IV (VSD4), exhibits robust inhibition of the 1KαPMTX-evoked N1742K response with IC50 of 40 nM.
DC10668	GYY4137 morpholine salt Featured	GYY 4137 is a Water-soluble, slow-releasing hydrogen sulfide donor.
DC22106	GZ389988	GZ389988 (GZ-389988) is a novel potent, selective, locally delivered TrkA inhibitor for the treatment osteoarthritis.
DC7147	GZD824 Featured	GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
DC20118	GZD856 Featured	GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities. Also a Bcr-AblT315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant.
DC21105	H3B-8800 Featured	H3B8800 is an orally available splicing modulator that targets spliceosome SF3b complex containing either WT or mutant SF3B1 (binding IC50 of 0.3-2 nM),demonstrates dose-dependent inhibition of both canonical splicing and aberrant splicing induced by mutant SF3B1 in in vitro assays of biochemical splicing, induces lethality in spliceosome-mutant cancer cells.. H3B-8800 potently and preferentially kills spliceosome-mutant epithelial and hematologic tumor cells.
DC20106	H4R antagonist 1	H4R antagonist 1
DC9795	HA-15 Featured	HA15 displayed anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
DC9567	Halcinonide	Halcinonide is a high potency corticosteroid used topically in the treatment of certain skin conditions.
DC9749	Halofuginone	Halofuginone is the competitively inhibitor of prolyl-tRNA synthetase with Ki of 18.3 nM.It could also down-regulate Smad3 and blocked TGF-β signaling at 10 ng/ml in mammal.
DCAPI1229	Haloperidol (Haldol)	Haloperidol (Haldol)
DC10741	HAMNO (NSC111847) Featured	HAMNO is a novel protein interaction inhibitor of replication protein A (RPA).
DC21106	HAP-12	HAP-12 is a small molecule HBV capsid assembly effector that inhibits HBV DNA replication with EC50 of 0.5 uM..
DC23253	HAR-171	HAR-171 is a small molecule gp120-CD40 blocker that acts as a highly potent HIV entry inhibitor with IC50 of 0.43 uM against YTA48P virus with no significant cytotoxicity (CC50>120 uM)..
DC12224	H-Arg-4MβNA	H-Arg-4MβNA is a substrate for cathepsin H, used for the detection of enzyme activity in gel electrophoresis.
DC23634	HBT1	HBT1 is a novel potent AMPA receptor potentiator with lower agonistic effect compared with LY451395 and OXP1..
DC20917	HBV Capsid inhibitor 3711	HBV Capsid inhibitor 3711 (Compound 3711) is a nonnucleosidic HBV inhibitor, inhibits hepatitis B virus replication by inducing genome-free capsid formation.
DC23783	HBX 28258	HBX 28258 is a potent, selective USP7 inhibitor with IC50 of 22.6 uM, exhibits high selectivity over other USP members, such as USP8, USP5, USP2, and USP20 (IC50 >200 uM), and no activity against UCH-L1, UCH-L3 and SENP1.
DC8207	HBX41108 Featured	HBX 41108 is an inhibitor of ubiquitin-specific protease (USP) 7 activity (IC50 = 424 nM).
DC5200	HC-030031 Featured	HC-030031 is a selective TRPA1 channel blocker that antagonizes AITC- and formalin-evoked calcium influx with IC50 of 6.2 μM and 5.3 μM respectively.
DC12197	HC-056456 (3,4-Bis(2-thienoyl)-1,2,5-oxadiazole-N-oxide)	HC-056456 is an effective but not perfectly-selective blocker of CatSper channels. The [Na+]i rise is slowed by HC-056456 (IC50~3 µM).
DC21108	HC-070	HC-070 is a potent, selective, orally active inhibitor of TRPC4 and TRPC5 channel with IC50 of 9.3 and 46 nM (calcium influx inhibition), respectively.
DC12620	hClpP activator D9 Featured	hClpP activator D9 is a potent and species-selective activator of human ClpP (hClpP, human Caseinolytic protease P) by mimicking the natural chaperone ClpX..

Other Targets

Customized Consultation X

Your information is safe with us. * Required Fields.